Detalles de la búsqueda
1.
The Effects of Adalimumab in Behçet Disease Patients on Clinical Manifestations and on Pro-Inflammatory Cytokines Milieu: Long-Term Follow-Up.
Isr Med Assoc J;
22(5): 289-293, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32378820
2.
[THE INPUT OF MEASURING INFLIXIMAB LEVELS AND LEVELS OF ANTIBODIES TO INFLIXIMAB IN THE MANAGEMENT OF PATIENTS WITH RHEUMATIC DISEASES].
Harefuah;
156(7): 427-430, 2017 Jul.
Artículo
en Hebreo
| MEDLINE | ID: mdl-28786280
3.
Safety of Corticosteroid Treatment in Rheumatologic Patients With Markers of Hepatitis B Viral Infection: Pilot Evaluation Study.
J Clin Rheumatol;
22(7): 364-8, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27660934
4.
Long-term follow-up of patients with scleroderma interstitial lung disease treated with intravenous cyclophosphamide pulse therapy: a single-center experience.
Isr Med Assoc J;
17(3): 150-6, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25946765
5.
Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.
Rheumatol Int;
33(6): 1495-504, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23239037
6.
Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity.
Immunity;
19(5): 679-88, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14614855
Resultados
1 -
6
de 6
1
Próxima >
>>